TransMedics Group, Inc. (TMDX) Current Ratio
- Current ratio · latest quarter: Value 6.62×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.62× | Current assets / current liabilities. $651.12M ÷ $98.28M ≈ 6.62× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 651.12M USD | Assets, Current |
| Current obligations | 98.28M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 104.14M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 54.14M USD | Inventory, Net |
| Payables | 12.91M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 20.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $651.12M | $98.28M | (m) | (m) | $104.14M | $54.14M | $12.91M | $20.00M | 6.62× |
| 2026-03-31 | $619.28M | $91.92M | (m) | (m) | $90.73M | $49.89M | $11.15M | $15.00M | 6.74× |
| 2025-12-31 | $637.78M | $89.31M | (m) | (m) | $84.28M | $48.88M | $10.35M | $10.00M | 7.14× |
| 2025-09-30 | $613.00M | $79.72M | (m) | (m) | $80.70M | $44.51M | $12.16M | $5.00M | 7.69× |
| 2025-06-30 | $558.13M | $56.62M | (m) | (m) | $104.85M | $38.87M | $9.54M | (m) | 9.86× |
| 2025-03-31 | $505.92M | $55.60M | (m) | (m) | $142.03M | $43.38M | $10.60M | (m) | 9.10× |
| 2024-12-31 | $497.22M | $59.91M | (m) | (m) | $97.72M | $46.55M | $10.29M | (m) | 8.30× |
| 2024-09-30 | $492.48M | $60.05M | $330.09M | (m) | $90.13M | $52.15M | $13.13M | (m) | 8.20× |
| 2024-06-30 | $509.26M | $54.33M | $362.75M | (m) | $81.16M | $48.67M | $13.03M | (m) | 9.37× |
| 2024-03-31 | $488.31M | $50.22M | $350.22M | (m) | $81.94M | $48.54M | $9.22M | (m) | 9.72× |
| 2023-12-31 | $510.65M | $54.93M | (m) | (m) | $63.58M | $44.23M | $12.72M | (m) | 9.30× |
| 2023-09-30 | $536.72M | $49.10M | $427.11M | (m) | $60.65M | $39.37M | $12.84M | (m) | 10.93× |
| 2023-06-30 | $662.65M | $32.02M | $582.21M | (m) | $47.52M | $30.55M | $7.03M | (m) | 20.70× |
| 2023-03-31 | $261.73M | $28.64M | $195.38M | (m) | $38.62M | $23.96M | $4.33M | (m) | 9.14× |
| 2022-12-31 | $252.29M | $23.66M | $201.18M | (m) | $27.61M | $20.61M | $3.34M | (m) | 10.66× |
| 2022-09-30 | $250.59M | $20.69M | $204.46M | (m) | $22.04M | $18.57M | $3.08M | (m) | 12.11× |
| 2022-06-30 | $95.11M | $22.74M | $30.39M | $27.70M | $12.98M | $17.47M | $5.71M | (m) | 4.18× |
| 2022-03-31 | $105.80M | $20.26M | $17.90M | $54.10M | $11.72M | $16.71M | $2.93M | (m) | 5.22× |
| 2021-12-31 | $118.70M | $23.24M | $25.58M | $66.87M | $5.93M | $14.86M | $6.65M | (m) | 5.11× |
| 2021-09-30 | $125.58M | $15.92M | $22.50M | $80.36M | $4.15M | $14.87M | $2.68M | (m) | 7.89× |
| 2021-06-30 | $135.05M | $15.08M | $25.31M | $86.94M | $6.27M | $13.01M | $2.39M | (m) | 8.96× |
| 2021-03-31 | $140.54M | $11.76M | $26.73M | $91.39M | $7.39M | $11.82M | $1.29M | $0.00 | 11.95× |
| 2020-12-31 | $146.77M | $11.88M | $24.58M | $101.06M | $6.86M | $11.93M | $1.21M | (m) | 12.36× |
| 2020-09-30 | $154.13M | $13.62M | $21.40M | $111.32M | $6.14M | $12.98M | $778.00K | $0.00 | 11.31× |
| 2020-06-30 | $158.23M | $13.82M | $51.15M | $88.22M | $4.43M | $12.55M | $3.72M | $0.00 | 11.45× |
| 2020-03-31 | $91.70M | $15.04M | $24.74M | $47.82M | $6.13M | $11.36M | $4.86M | $0.00 | 6.10× |
| 2019-12-28 | $100.00M | $16.11M | $20.09M | $60.60M | $6.56M | $11.22M | $7.25M | (m) | 6.21× |
| 2019-09-28 | $107.37M | $14.64M | $20.41M | $67.86M | $6.46M | $10.54M | $4.77M | (m) | 7.33× |
| 2019-06-29 | $116.13M | $15.38M | $47.24M | $48.99M | $7.11M | $11.22M | $6.66M | (m) | 7.55× |
| 2019-03-30 | $30.06M | $16.20M | $12.21M | (m) | $5.15M | $11.29M | $5.50M | (m) | 1.86× |
| 2018-12-29 | $34.79M | $12.55M | $20.24M | (m) | $3.44M | $9.28M | $4.72M | (m) | 2.77× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |